AMS
Price
$1.22
Change
+$0.06 (+5.17%)
Updated
Nov 9, 02:30 PM (EDT)
Capitalization
7.71M
3 days until earnings call
Intraday BUY SELL Signals
EFFE
Price
$23.89
Change
-$0.68 (-2.77%)
Updated
Nov 6 closing price
Net Assets
126.22M
Intraday BUY SELL Signals
Interact to see
Advertisement

AMS vs EFFE

AMS vs EFFE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AMS vs. EFFE commentary
Nov 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMS is a StrongBuy and EFFE is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AMS with price predictions
Nov 06, 2026

AMS's RSI Indicator stays in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMS advanced for three days, in 127 of 200 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

AMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMS as a result. In 94 of 138 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.

The Moving Average Convergence Divergence Histogram (MACD) for AMS turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 28 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

The Aroon Indicator for AMS entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.334) is normal, around the industry mean (204.532). P/E Ratio (-4.462) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (2.498). Dividend Yield (0.164) settles around the average of (0.154) among similar stocks. P/S Ratio (0.313) is also within normal values, averaging (2.688).

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. AMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for EFFE with price predictions
Nov 06, 2026

EFFE's RSI Oscillator sits in oversold zone for 18 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

EFFE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EFFE as a result. In 5 of 12 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 42%.

The Aroon Indicator for EFFE entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

FUNDAMENTALS RATINGS
AMS: Fundamental Ratings
AMS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMSEFFE
RSI
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
69%
Momentum
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
42%
MACD
ODDS (%)
Bearish Trend 4 days ago
61%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 4 days ago
43%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
34%
Advances
ODDS (%)
Bullish Trend 13 days ago
63%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
65%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
4%
COMPARISON
Comparison
Nov 10, 2026
Stock price -- (AMS: $1.16)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMS’s FA Score shows that 2 FA rating(s) are green while .

  • AMS’s FA Score: 2 green, 3 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMS’s TA Score shows that 4 TA indicator(s) are bullish.

  • AMS’s TA Score: 4 bullish, 4 bearish.

Price Growth

AMS (@Hospital/Nursing Management) experienced а -8.66% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.90%. For the same industry, the average monthly price growth was +3.50%, and the average quarterly price growth was +12.05%.

Reported Earning Dates

AMS is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Hospital/Nursing Management (+1.90% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

AMS and

Correlation & Price change

A.I.dvisor tells us that AMS and BKD have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMS and BKD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMS
1D Price
Change %
AMS100%
-0.85%
BKD - AMS
23%
Poorly correlated
-16.65%
PNTG - AMS
21%
Poorly correlated
-9.10%
ADUS - AMS
15%
Poorly correlated
-1.97%
HCA - AMS
14%
Poorly correlated
-2.46%
HCSG - AMS
12%
Poorly correlated
-3.31%
More

EFFE and

Correlation & Price change

A.I.dvisor tells us that EFFE and IBN have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EFFE and IBN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EFFE
1D Price
Change %
EFFE100%
-2.78%
IBN - EFFE
15%
Poorly correlated
+4.18%
AMS - EFFE
12%
Poorly correlated
-0.85%
HDB - EFFE
10%
Poorly correlated
+1.78%
TME - EFFE
7%
Poorly correlated
+1.16%
BID - EFFE
2%
Poorly correlated
+0.30%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NEBX6.850.88
+14.74%
Tradr 2X Long NBIS Daily ETF (NEBX)
DVSP27.480.09
+0.35%
WEBs SPY Defined Volatility ETF (DVSP)
CARY20.360.01
+0.05%
Angel Oak Income ETF (CARY)
CBTJ19.13-0.06
-0.30%
Calamos Bitcoin 80 Series Structured Alt Protection ETF - January (CBTJ)
KBWP139.69-3.22
-2.25%
Invesco KBW Property & Casualty Insurance ETF (KBWP)